logo

HomeArticlesServicePriceAbout

Menu

Home
Articles
Service
Price
Search
About
logo
logo

Company

AboutTerms of Service Privacy Policy

Social

LinkedIn Twitter Discord

Contact

contact@coresixteen.com coresixteen.com
Company NameCORE16 Inc.
CEODavid Cho
Business Registration Number762-81-03235
officePhone070-4225-0201
Address83, Uisadang-daero, Yeongdeungpo-gu, Seoul, 07325, Republic of KOREA

Test1

article
셀스마트 판다 프로필 사진셀스마트 판다
A Hidden Gem in the Midst of a Market Meltdown
created At: 4/9/2025
Neutral
Neutral
This analysis was written from a neutral perspective. We advise you to always make careful and well-informed investment decisions.
PM
Philip Morris International
7
0
0
Fact
FDA grants first-ever approval for nicotine pouch product Zyn Strong momentum in smoke-free products and marketing capabilities Bullish technical signals from Aroon and MACD +30% YTD stock performance, outperforming the S&P 500
Opinion
Philip Morris is executing a successful transformation from traditional tobacco to reduced-risk products. Even in turbulent markets, it continues to deliver.
Core Sell Point
In a crashing market, PM stands out with bullish technical signals and a strong pivot toward smoke-free growth—making it a high-conviction play amid global uncertainty.

SellSmart’s latest algorithm, affectionately dubbed “When Nerds Rule the World” might sound quirky, but its results are nothing short of compelling. The system meticulously filters top-tier U.S. large-cap stocks through data-driven criteria to surface new opportunities worth watching.

And just recently, the “Nerd Algorithm” flagged its newest find. Let’s dive in.

👉 The Pick: Philip Morris International (PM)

Operating in over 180 countries, Philip Morris International is a global tobacco powerhouse, known for brands like Marlboro, L&M, and Chesterfield. But this isn’t just your typical cigarette company. PM is actively reinventing itself—shifting away from traditional tobacco and toward a "smoke-free future" by investing in next-generation nicotine products.

🔍 Why PM?

📌 FDA Approval Accelerates Smoke-Free Growth

In Jan 2025, the U.S. FDA officially approved Zyn, PM’s nicotine pouch product, as the first of its kind recognized as a cessation aid for smokers.
This regulatory milestone gives PM a first-mover edge, allowing it to expand its smoke-free portfolio and tap into a rapidly growing consumer segment.

📌 Resilience Amid a Global Selloff

Despite the broad market crash on Apr 4, 2025, PM stood out with strong technical momentum and solid fundamentals. On Mar 31 and Apr 3, two bullish indicators—Aroon and a MACD breakout—flashed in tandem. Historically, these signals have been followed by steady gains within 2–3 weeks.

And it’s not just technicals. PM’s Sharpe Ratio currently stands at 2.63, a sign of high risk-adjusted returns. For context, a Sharpe Ratio above 1 is considered solid; PM more than doubles that benchmark.

In short, while volatility rattles the broader market, PM offers a rare blend of innovation, stability, and upside.


📌 You'll find ongoing analysis on PM and other high-potential picks in the 'Events' section.

[Compliance Note]

  • All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.

  • The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.

  • Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

7
0
0
Comments
0
Please leave a comment first